Homology Medicines (BATS:FIXX) Insider Shelia Violette Sells 2,798 Shares of Stock

Homology Medicines, Inc. (BATS:FIXX) insider Shelia Violette sold 2,798 shares of the business’s stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $16.56, for a total transaction of $46,334.88. Following the transaction, the insider owned 127,771 shares in the company, valued at $2,115,887.76. This represents a 2.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Homology Medicines Price Performance

FIXX stock traded down $0.16 during trading on Thursday, reaching $12.73. The company had a trading volume of 978 shares, compared to its average volume of 1,230. Homology Medicines, Inc. has a 52 week low of $12.02 and a 52 week high of $14.30.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.